What is "gomiliximab"

n. A chimeric monoclonal antibody used as an immunosuppressive drug in the treatment of allergic asthma.

Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23). The drug is a chimeric antibody from Macaca irus and Homo sapiens.

This drug was developed by IDEC Pharmaceuticals Corporation.